Skip to Main Content

Author Details

Mark Raffeld
Center for Cancer Research, National Cancer Institute
1981
410
96
PMIDPaper TitleJournal TitlePublished Year
38031352Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.J Cutan Pathol2024
38031352Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.J Cutan Pathol2024
37988030Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.Am J Surg Pathol2024
37988030Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.Am J Surg Pathol2024
36264007A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.Br J Haematol2023
35838483Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>.Autophagy2023
36264007A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.Br J Haematol2023
37966258Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.Cancer Res Commun2023
36461146Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).Am J Surg Pathol2023
37227187Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.Clin Cancer Res2023
36598455Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.Am J Surg Pathol2023
37966258Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.Cancer Res Commun2023
35838483Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>.Autophagy2023
37227187Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.Clin Cancer Res2023
36461146Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).Am J Surg Pathol2023
36598455Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.Am J Surg Pathol2023
34555175Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.Neuro Oncol2022
35587280Recurrent ACVR1 mutations in posterior fossa ependymoma.Acta Neuropathol2022
35650679Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.Am J Surg Pathol2022
36201019Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.Acta Neuropathol2022
35982947Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in <i>PMS2</i>.Front Oncol2022
35469800Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease.Urology2022
34555175Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.Neuro Oncol2022
34957617An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.Cytopathology2022
35103816High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.Acta Neuropathol2022
35587280Recurrent ACVR1 mutations in posterior fossa ependymoma.Acta Neuropathol2022
35650679Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.Am J Surg Pathol2022
35469800Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease.Urology2022
36201019Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.Acta Neuropathol2022
35982947Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in <i>PMS2</i>.Front Oncol2022
35103816High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.Acta Neuropathol2022
34957617An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.Cytopathology2022
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
35481284CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.Oncoimmunology2021
34283064Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma.Cancers (Basel)2021
33527979Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.Am J Clin Pathol2021
33615670Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.Am J Med Genet A2021
34326811Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.Front Endocrinol (Lausanne)2021
32929178The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.Mod Pathol2021
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
34607348Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.Blood Adv2021
35481284CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.Oncoimmunology2021
33615670Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.Am J Med Genet A2021
33527979Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.Am J Clin Pathol2021
34607348Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.Blood Adv2021
34326811Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.Front Endocrinol (Lausanne)2021
34283064Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma.Cancers (Basel)2021
32929178The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.Mod Pathol2021
31439678Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.Haematologica2020
32132976A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.Front Endocrinol (Lausanne)2020
  • 1 - 50 of 820

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
University of Washington
Career Start Year 2010
Number of shared co-authors 5
Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 6
Intermountain Medical Center
Career Start Year 2007
Number of shared co-authors 0
Intermountain Medical Center
Career Start Year 2001
Number of shared co-authors 0
KTH - Royal Institute of Technology
Career Start Year 2000
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 3
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Western University
Career Start Year 1999
Number of shared co-authors 0
Institute for Cancer Genetics, Columbia University
Career Start Year 1999
Number of shared co-authors 0
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Merck & Co.
Career Start Year 1998
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 2
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 5
University of Paris
Career Start Year 1993
Number of shared co-authors 1
Kyoto University
Career Start Year 1993
Number of shared co-authors 5
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 10
Center for Biomedical Informatics & Information Technology, National Cancer Institute
Career Start Year 1991
Number of shared co-authors 1
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 11
University of California San Diego
Career Start Year 1985
Number of shared co-authors 7
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 5
University of Utah
Career Start Year 1982
Number of shared co-authors 7
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 2
Institute for Cancer Genetics, Columbia University
Career Start Year 1978
Number of shared co-authors 5
Lehigh Valley Hospital
Career Start Year 1977
Number of shared co-authors 4
University of California San Diego
Career Start Year 1977
Number of shared co-authors 8

Collaborators

Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 182
National Cancer Institute, National Institutes of Health
Co-authored papers 105
National Cancer Institute, National Institutes of Health
Co-authored papers 36
Center for Cancer Research, National Cancer Institute
Co-authored papers 25
Co-authored papers 17
Meyer Cancer Center
Co-authored papers 13
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 12
Co-authored papers 11
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers 11
University of Colorado School of Medicine
Co-authored papers 11
National Cancer Institute, National Institutes of Health
Co-authored papers 10
National Cancer Institute
Co-authored papers 9
National Cancer Institute
Co-authored papers 9
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
National Cancer Institute
Co-authored papers 7
National Cancer Institute
Co-authored papers 7
The Francis Crick Institute
Co-authored papers 7
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 6
Indiana University School of Medicine
Co-authored papers 6
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 6
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 6
Co-authored papers 6
National Institutes of Health
Co-authored papers 5
Center for Cancer Research
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Karolinska Institute
Co-authored papers 5
Co-authored papers 5
National Cancer Institute, National Institutes of Health
Co-authored papers 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 5